About Ospicare Life Sciences Private Limited
Data last updated:
Ospicare Life Sciences Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 04 October 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74999MH2020PTC347190. Its GSTIN is 27AADCO2860L1Z6 (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Ramchandra Govind Shevade and Chandan Keshav Bhave.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at D 601 Vijay Nagar Chs Swami Nityanand Road Andheri (East), Mumbai, Maharashtra, India – 400069.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.52 Cr, a growth of 20% compared to the previous year. For the same year it recorded a net profit of ₹1.07 Lakh (net margin 0.4%) and EBITDA of ₹9.21 Lakh (EBITDA margin 3.7%). Revenue has grown at a compounded annual rate (CAGR) of 12% over three years.
The company has about 20 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹84 Lakh on record.
For more details, the company can be reached via its website ospicare.in.
Company details
Contact details
Ospicare Life Sciences Private Limited's registered office is in Mumbai, Maharashtra. Its website is ospicare.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressD 601 Vijay Nagar Chs Swami Nityanand Road Andheri (East), Mumbai, Maharashtra, India – 400069
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Ospicare Life Sciences Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Ospicare Life Sciences is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Ospicare Life Sciences Private Limited, buy the company report.
Financials of Ospicare Life Sciences Private Limited
FY 2025 filings availableOspicare Life Sciences Private Limited reported revenue of ₹2.52 Cr (up 20% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 12% over three years, including 20% growth in the latest year. EBITDA rose 206% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹9.21 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.07 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.7% | ||||
| Net Profit Margin | 0.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Ospicare Life Sciences Private Limited, buy the company report.
Board of directors of Ospicare Life Sciences Private Limited
Ospicare Life Sciences has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ramchandra Govind Shevade | Director | 12 Feb 2022 | 4 Years 8 Months | Current |
| Chandan Keshav Bhave | Director | 04 Oct 2020 | 6 Years 0 Months | Current |
Peer comparison
Ospicare Life Sciences Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Fusion Life Sciences Private Limited | ₹2.52 Cr (FY 2022) | 37.0% | Delhi, India | |||
| Annkn Enterprises Private Limited | ₹2.52 Cr (FY 2024) | 0.0% | Patna, Bihar, India | |||
| Operose Energy Private Limited | ₹2.52 Cr (FY 2024) | 196.0% | Paschim Burdwam, West Bengal, India | |||
| Femstex Trading Company Private Limited | ₹2.52 Cr (FY 2025) | -51.0% | Mumbai, Maharashtra, India | |||
| Toolsmyne Private Limited | ₹2.52 Cr (FY 2025) | 41.0% | Vijayawada, Andhra Pradesh, India | |||
| Ospicare Life Sciences Private Limitedthis company | ₹2.52 Cr (FY 2025) | ₹1.07 Lakh | 0.4% | 20.0% | 20 | Mumbai, Maharashtra, India |
| Accretion Spice Garden Private Limited | ₹2.52 Cr (FY 2025) | 1.0% | Indore, Madhya Pradesh, India | |||
| LSP Fire Engineering Private Limited | ₹2.52 Cr (FY 2025) | -10.0% | Palwal, Haryana, India | |||
| Advantagesai Projects Private Limited | ₹2.52 Cr (FY 2025) | -10.0% | Aurangabad, Maharashtra, India | |||
| Jagriti Bricks Private Limited | ₹2.52 Cr (FY 2021) | 11.0% | Dadri, Uttar Pradesh, India | |||
| R S Woods Private Limited | ₹2.52 Cr (FY 2025) | -63.0% | New Delhi, Delhi, India |
To see the full peer comparison of Ospicare Life Sciences Private Limited, buy the company report.
Auditor
Ospicare Life Sciences Private Limited is audited by R. R. Ranade & Co. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| R. R. Ranade & Co. | FY 2023 | 108614W |
Shareholding
The shareholding of Ospicare Life Sciences Private Limited is on record for 3 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Ospicare Life Sciences Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 30 Dec 2021 | 100528282 | Tjsb Sahakari Bank Limited | ₹9 Lakh | Open | |
| 26 Feb 2021 | 100429354 | Tjsb Sahakari Bank Limited | ₹75 Lakh | Open |
To see the full charge records of Ospicare Life Sciences Private Limited, buy the company report.
Total charge records: 2 View all charges
Legal cases
No court or tribunal cases involving Ospicare Life Sciences Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Ospicare Life Sciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Ospicare Life Sciences Private Limited has a workforce of 20 employees on its EPFO records as of Apr 08, 2024, across 1 active EPFO establishment.
GST
Ospicare Life Sciences has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AADCO2860L1Z6 | Maharashtra | Active | 05 Nov 2020 |
To see the full GST registrations and return filing status of Ospicare Life Sciences Private Limited, buy the company report.
Recent activity
Ospicare Life Sciences Private Limited has 4 board changes on record since 2020: 2 appointments and 2 cessations. The latest: Ramchandra Govind Shevade ceased to be Additional Director on 30 Sep 2022.
Frequently asked questions
Ospicare Life Sciences is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 04 October 2020 (6+ years old) and is registered under CIN U74999MH2020PTC347190.
Ospicare Life Sciences has 2 current directors:
- Ramchandra Govind Shevade - Director
- Chandan Keshav Bhave - Director
The latest financial statements of Ospicare Life Sciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Ospicare Life Sciences is 27AADCO2860L1Z6, registered in Maharashtra.
The CIN (Corporate Identification Number) of Ospicare Life Sciences is U74999MH2020PTC347190. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ospicare Life Sciences was incorporated on 04 October 2020, making it 6+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Ospicare Life Sciences by revenue are Fusion Life Sciences Private Limited, Annkn Enterprises Private Limited, Operose Energy Private Limited, Femstex Trading Company Private Limited, Toolsmyne Private Limited and 5 more, all in the same principal business activity (wholesale trading).
Ramchandra Govind Shevade ceased to be Additional Director on 30 Sep 2022. Ramchandra Govind Shevade was appointed as Director on 12 Feb 2022. Kalpana Keshav Bhave ceased to be Director on 18 Jan 2022. Ospicare Life Sciences has 4 board changes on record in total.
Ospicare Life Sciences can be reached through the website ospicare.in. Its registered office is in Mumbai, Maharashtra, India.
The registered office of Ospicare Life Sciences is at D 601 Vijay Nagar Chs Swami Nityanand Road Andheri East, Mumbai, Maharashtra, India – 400069.
Ospicare Life Sciences operates in the pharma industry, in the drug formulation and development segment.